• Molecular NameAdefovir
  • Synonymadefovir dipivoxil; Adefovir pivoxil; Adefovirdipivoxl; ADV; bis-POM PMEA; GS-840; PMEA
  • Weight273.189
  • Drugbank_IDDB00718
  • ACS_NO106941-25-7
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-1.82
  • pkaN/A
  • LogD (pH=7, predicted)-6.22
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.56
  • LogSw (predicted, AB/LogsW2.0)4.97
  • Sw (mg/ml) (predicted, ACD/Labs)5.13
  • No.of HBond Donors4
  • No.of HBond Acceptors9
  • No.of Rotatable Bonds5
  • TPSA146.19
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn orally-administered nucleotide analog reverse transcriptase inhibitor (ntRTI).
  • Absorption_value16.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability12.0
  • Protein binding4.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life7.5 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A